ENTRI

ENTRI provides flexible, ready-to-use cGMP cleanroom infrastructure with options for partial or full facility use, supporting biotech, pharma and CDMO companies from clinical to commercial supply. It enables manufacturing of biologics, RNA-based products and cell and gene therapies, with other modalities supported subject to fit.

ENTRI combines in-house control with external site benefits, allowing full ownership of processes and IP, flexible operations, dedicated capacity, and compliance with cGMP and global regulatory standards. This reduces capital expenditure and accelerates timelines.

Located in Brisbane, Australia, ENTRI sits within the Translational Research Institute ecosystem, a biomedical cluster connecting manufacturing, research and clinical translation.